Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

ABCL FY 2018 Earnings — AbCellera Biologics Inc. Revenue & Financial Results | Market Cap Arena

ABCLAbCellera Biologics Inc.

$1B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M

Gross Profit

$9M100.0% margin

Operating Income

-$753,000-8.5% margin

Net Income

$309,0003.5% margin

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$2M

Stock-Based Comp.

$615,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$10M

Stockholders' Equity

$12M

Cash & Equivalents

$10M

← Q1 2019 All Quarters